Fierce Pharma

Pharma giant AstraZeneca extended its supply deal with Michigan-based medical [...]

CMS’ Innovation Center has released two new drug pricing models [...]

Boehringer’s Jascayd can now crack open the rare progressive pulmonary [...]

Slated for a Dec. 26 decision on Cytokinetics’ aficamten, the [...]

Samsung Bio’s U.S. subsidiary will pay $280 million to acquire [...]

Updates on DTC advertising and DTP programs, as well as [...]

After a series of ownership changes, Andexxa is slated to [...]

The Elevidys-related manufacturing shortfalls were described in one of two [...]

Sixteen months after luring former Roche dealmaker James Sabry, M.D., [...]

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, GSK, Merck [...]